Regarding combinational therapeutic strategies, cholesterol-coated NPs loaded with retinoic acid and anti-PD-L1 immune checkpoint inhibitors effectively disrupted the upregulated STAT3/NF-κB pathway crosstalk in CRC [76]. This evidence concerns the gene NFKB1 and colorectal carcinoma.